Yali Shen
17PUBLICATIONS
60CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (17)
Sort by Publication Date:
|May 12, 2025
Comprehensive molecular profiling of FH-deficient renal cell carcinoma identifies molecular subtypes and potential therapeutic targets.Xingming Zhang, Junjie Zhao, Xiaoxue Yin
|Mar 04, 2025
The Prognostic Value of the Prostate Adenocarcinoma With Ductal Feature in Patients With Advanced Prostate Cancer Treated With Abiraterone Acetate.Yifu Shi, Xinyuan Wei, Fengnian Zhao
|Oct 28, 2024
Assessing the predictive value of intraductal carcinoma of the prostate (IDC-P) in determining abiraterone efficacy for metastatic hormone-sensitive prostate cancer (mHSPC) patients.Xinyuan Wei, Jinge Zhao, Ling Nie
|Aug 23, 2024
Development and validation of a novel nomogram to avoid unnecessary biopsy in patients with PI-RADS category ≥ 4 lesions and PSA ≤ 20 ng/ml.Hong Zeng, Yuntian Chen, Jinge Zhao
|Apr 17, 2024
Predicting abiraterone efficacy in advanced prostate cancer: Insights from marker of proliferation Ki67.Fengnian Zhao, Jinge Zhao, Xinyuan Wei
|Mar 21, 2024
Memory/Active T-Cell Activation Is Associated with Immunotherapeutic Response in Fumarate Hydratase-Deficient Renal Cell Carcinoma.Junru Chen, Xu Hu, Junjie Zhao
Pageof 3
